Form 4: Willis Towers Watson Executive Julie Jarecke Gebauer Reports Share Transactions

Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson, reports acquisition and disposal of ordinary shares and dividend equivalent rights related to restricted share units.

Summary

• On April 1, 2024, Julie Jarecke Gebauer, Head of Health, Wealth & Career at Willis Towers Watson PLC, reported transactions involving the company's ordinary shares.
• Gebauer acquired 1,559 time-based restricted share units (RSUs) and 10 dividend equivalent rights, each representing one WTW Ordinary Share.
• She also disposed of shares to cover tax obligations related to the vesting and settlement of RSUs granted in 2022 and 2023.
• The disposals involved withholding 122 shares related to the vesting of 386 RSUs granted on April 1, 2022, 171 shares related to the vesting of 434 RSUs granted on April 1, 2023, and 186 shares related to the vesting of 471 RSUs granted on April 1, 2023.
• Following these transactions, Gebauer directly owns 73,876.009 ordinary shares and indirectly owns 534 shares through the Dane Adam Gebauer Management Trust UA Feb 18, 2012 and 534 shares through the Jeffrey Austin Gebauer Management Trust UA Feb 18, 2012.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and reflect standard executive compensation practices. The acquisition of RSUs signals continued alignment with the company's success.

Positives

• The acquisition of 1,559 RSUs indicates continued alignment of the executive's interests with the company's long-term performance.
• The acquisition of 10 dividend equivalent rights further increases her stake in the company.

Negatives

• The disposal of shares to cover tax obligations, while routine, slightly reduces Gebauer's direct shareholding.

Future Outlook

The RSUs vest ratably over a three-year period, suggesting continued alignment of the executive's interests with the company's performance over that timeframe.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the executive's continued investment in the company through equity-based compensation.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded companies like Willis Towers Watson to align executive compensation with shareholder value.
• Companies such as Aon and Mercer, which are competitors of Willis Towers Watson, also utilize similar equity-based compensation plans for their executives.
• The vesting schedules and terms of the RSUs are likely comparable to industry norms for executive compensation packages.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The reporting provides transparency to shareholders regarding executive compensation and ownership.

Key Dates